Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Wisp is now offering at-home testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium.
Following evidence showing that bacterial vaginosis affects both men and women, Wisp has launched a male BV partner treatment.
Wisp patients enrolled in its weight care program can now access nutrition counseling services with Nourish.
The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs.
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
Wisp members can now order TBD Health’s STI/STD testing kits on Wisp’s website for free delivery.
Walmart’s decision to shutter its healthcare division reflects just how difficult it is to achieve profitability in the primary care and telehealth markets. Experts think retailers simply aren’t prepared to handle the bevy of challenges that come along with delivering healthcare — but could this news also be a sign of the system being broken?
President Joe Biden has signed an executive order that aims to improve women's health research, among other things. Several women's health executives came out in support.
Women's health advocates overwhelmingly came out in support of the White House's $100 million investment into women's health research. However, some noted shortcomings in where the funding is going.
Yusuf Qasim, President of Payments Optimization at Zelis, discussed how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure.
TBD Health is moving into the B2B healthcare space by partnering with digital health companies, starting with FOLX Health and Wisp.